A biopharmaceutical company
Prescription Drug User Fee Act reauthorization.
FDA issues.
Diabetes drugs issues. Diabetes issues.
Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Diabetes research issues. Medicare coverage and reimbursement issues.
Diabetes issues.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
PHA - Pharmacy HCR - Health Issues MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
SHARON COHEN ANNE MARIE POLAK THOMAS B SPARKMAN SHARON COHEN THOMAS B SPARKMAN SHARON COHEN THOMAS B SPARKMAN SHARON COHEN THOMAS B SPARKMAN